Collins Stewart
http://www.collins-stewart.com/index.aspCollins Stewart is an independent investment banking group.
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 01/13: MU, ONNN, DE, EMC Upgraded; SMSI, ELN, ITT, COP Downgraded
-
Collins Stewart Starts GS, BCS at Buy, MS, DB, UBS at Neutral
-
Collins Stewart Upgrades ON Semi (ONNN) to Buy
-
Collins Stewart Starts Kinetic Concepts (KCI) at Buy
-
Collins Stewart Downgrades Solarfun Power (SOLF) to Hold
-
Collins Stewart Boosts Price Target on Boston Scientific (BSX) 13% to $8.50
-
Jabil's (JBL) Diversification Makes It A Potential 2011 Winner - Barron's
-
Collins Stewart Downgrades Alcon (ACL) to Hold
-
Collins Stewart Upgrades Aegerion Pharmaceuticals (AEGR) to Buy
-
Notable Analyst Rating Changes 12/02: STP, PFG, INAP, SATC Upgraded; ARO, MHR, LEAP, TSL Downgraded
-
Collins Stewart Starts Cypress Semi (CY) at Buy
-
Collins Stewart Starts Atmel (ATML) at Buy
-
Collins Stewart Starts Stereotaxis (STXS) at Buy, Sets $4.50 Price Target
-
Collins Stewart Upgrades British American Tobacco (BTI) to Buy
-
Collins Stewart Starts Credit Suisse (CS) at Buy
-
Notable Analyst Rating Changes 11/15: SNV, HTWR, CL, JCG Upgraded; LLNW, THOR, AKAM, RAX Downgraded
-
Collins Stewart Upgrades Synovus Financial (SNV) to Buy
-
Collins Stewart Upgrades Statoil ASA (STO) to Buy
-
Collins Stewart Downgrades Auxilium Pharma (AUXL) to Neutral
-
Notable Analyst Rating Changes 11/04: KIM, PHM, QCOM, HMA Upgraded; MPWR, PT, SWIR, K Downgraded
-
Collins Stewart Starts BSX, STJ at Buy, MDT at Neutral
-
Collins Stewart Downgrades Sanmina-SCI Corp (SANM) to Neutral
-
Collins Stewart Upgrades Endo Pharmaceuticals (ENDP) to Buy
-
Collins Stewart Slaps a Sell Rating on Amylin (AMLN) Shares
-
Collins Stewart Downgrades King Pharmaceuticals (KG) to Neutral
-
Collins Stewart Downgrades Synaptics (SYNA) to Neutral
-
Collins Stewart Initiates Coverage on PNC Financial Services (PNC) with a Buy
-
Collins Stewart Starts Investment Service Stocks: BLK, TROW, LM, AMG at Buy, BEN, IVZ, FII, CNS at Hold
-
Notable Analyst Rating Changes 09/16: F, NFLX, OPEN, SI Upgraded; DNR, SVNT, COG, TOT Downgraded
-
Collins Stewart Announces Ratings Changes to Foreign Oil & Gas Stocks (E, STO & TOT)
-
Incyte (INCY) Shares Higher Amid Collins Stewart's New Buy Rating, $18 Price Target
-
Collins Stewart Downgrades Healthcare Facility Stocks AGP & CNC
-
Three Firms Downgrade Swiss Re (SWCEY) to Neutral/Hold
-
Collins Stewart Downgrades Swiss Re (SWCEY) to Hold
-
Notable Analyst Rating Changes 08/05: SIRI, PCS, RGS, ACAS Upgraded; VMC, SD, CNW, Q Downgraded
-
Collins Stewart Downgrades Qwest Communications (Q) to Hold
-
Collins Stewart Downgrades ISIS Pharmaceuticals (ISIS) to Hold
-
Collins Stewart Starts News Corp. (NWSA) at Buy, $18 Price Target
-
Sanofi-Aventis (SNY) Cuts Outlook Amid Generic Lovenox Approval; Analysts Mixed
-
Collins Stewart Downgrades Celestica (CLS) to Hold
-
Collins Stewart Downgrades Flextronics (FLEX) to Hold
-
IBM (IBM) Looks for Solid Q2 Results on IT, Enterprise Spending (ORCL, INTC)
-
Collins Stewart Initiates Coverage Retail (Drugs) Stocks
-
Collins Stewart Downgrades Roche (RHHBY) to Sell
-
Collins Stewart Initiates Coverage on JinkoSolar (JKS) with a Buy
-
Notable Analyst Rating Changes 06/25: O, TUP, VOD, BANR Upgraded; RIMM, LXU, AMSF, CXW Downgraded
-
Collins Stewart Upgrades Vodafone Group (VOD) to Trading Buy
-
Collins Stewart Reduces Estimates on BofA (BAC) Ahead of Reform Bill; Target Lowered to $20
-
Collins Stewart Starts Coverage on W.W. Grainger (GWW) with a Buy
-
Notable Analyst Rating Changes 06/23: KNOT, DWA, HOC, PPL Upgraded; WBD, EW, WL, ONNN Downgraded

